NCT01383967View on ClinicalTrials.gov

A Study of LY2979165 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

102

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions

Bipolar Disorder

Interventions

DRUG

LY2979165

Administered orally

DRUG

placebo

Administered orally

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Singapore

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT01383967 - A Study of LY2979165 in Healthy Subjects | Biotech Hunter | Biotech Hunter